12th Asia Regulatory Conference – Evolving landscapes: Asia’s role in driving more efficient, innovative and patient-centric regulatory environment
Date
3 - 6 December 2024
Time
07:30 - 10:30 CET (each day)
Hosts
IFPMA, together with Medicines Australia
Location
Online, free
Join us on 3-6 December 2024 for the next edition of the Asia Regulatory Conference, where we will explore the transformative power of regulatory collaboration across the region.
For over a decade, the Asia Regulatory Conference has served as a platform for meaningful and solutions-oriented exchanges among regulatory authorities, academia and industries on timely topics to evolve the regulatory landscape in the region.
For the next edition, the conference is organized by IFPMA in partnership with Medicines Australia. It will explore how regulatory reliance and work-sharing between national regulatory authorities can support pharmaceutical innovation and address regional health challenges.
Key focus areas for this edition will be:
- Enhancing innovation through collaborative regulatory frameworks: best practices for regulatory reliance in Asia and their global impact.
- Digital systems: Digital technology to enable efficient and streamlined regulatory processes.
- Pilots and capability building initiatives: Strategies to address regional health challenges through capability building and work-sharing between national regulatory authorities.
- Standard harmonization: Addressing the challenges and opportunities in the global regulatory landscape, through the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
At its twelfth edition, the Asia Regulatory Conference serves as a platform for stakeholders to share insights, experiences, and best practices in navigating the regulatory landscape in Asia. Participants will learn from each other and explore potential collaborations to address common challenges and opportunities in the regulatory field. The conference features panel discussions, keynote speeches, interactive Q&A sessions, creating a dynamic and engaging environment for knowledge exchange and collaborative discussions.
If you have any questions, please write to us at events@ifpma.org.
More information about the program and speakers will be shared in next months.
How to attend?
The conference is taking place virtually, on Zoom Events. Please register for the sessions you wish to attend, and you will receive a confirmation with the Zoom information. Sessions are held every day on 3-6 December 2024, from 07:30 – 10:30 CET. The conference is free to attend. To book your place click the button below and continue through to the registration page. The sessions will be recorded and made available to participants.
Program
- Fireside chat with patients
- Keynote session
- Access Consortium
- Reliance case studies & lessons learned
- Reliance across the product life cycle: PACs & GMPs
- Universal labelling: Enhancing global drug safety and accessibility for the new age
- Combining strengths: Preparing regulatory systems for combination products for advanced therapies and biologics
- ICH: Driving Global Harmonization to Advance Global Health
- eCTD Harmonization in Asia: Unlocking benefits of standardized submissions
- Advancing clinical trials: The impact of E6(R3) guideline